Reed Smith Llp
Recent News About Reed Smith Llp View More
-
Reed Smith’s Jennifer Yule DePriest named ’Notable Woman in Law’ by Crain’s Chicago Business
Jennifer Yule DePriest, managing partner of Reed Smith’s Chicago office, has been named a “Notable Woman in Law” by Crain’s Chicago Business, the firm announced. -
Best Lawyers in America features 237 Reed Smith lawyers
Six Reed Smith lawyers received Lawyer of the Year honors in their practice areas, and 178 of its lawyers were listed as 2024 Best Lawyers in America, in results that Best Lawyers released today. In addition, 59 younger lawyers at the law firm, which has 19 offices in the U.S., earned 2024 Ones to Watch designations. -
Reed Smith represents Prairie Capital on sale of Right at School
Global law firm Reed Smith has advised Prairie Capital, a Chicago-based middle market private equity firm, on the sale of Right at School, a Prairie Capital VI portfolio company to a larger private equity fund. -
Reed Smith represents Elevate Services on a senior secured term loan facility with Runway Growth Finance
Global law firm Reed Smith has advised Elevate Services, Inc. on a senior secured term loan facility with Runway Growth Finance LLC, a provider of growth loans to companies seeking an alternative to raising equity. -
Reed Smith advises Wind Point Partners portfolio company D&H United on its acquisition of Tanknology, Inc.
Global law firm Reed Smith announced that it has advised D&H United, a portfolio company of Wind Point Partners and a leading provider of mission-critical maintenance, testing and inspection services for fueling stations and electric vehicle charging infrastructure, with financing the acquisition of Tanknology, Inc. Tanknology is the global leader in environmental compliance testing, inspection and fuel quality solutions. -
Reed Smith announces Reed Smith advises Blue Rabbit on merger with Wedgewood Pharmacy
Global law firm Reed Smith today announced that it has advised Blue Rabbit, a Portland, Maine-based provider of veterinary prescription management and pharmacy solutions, on the regulatory aspects of its merger with Swedesboro, N.J.-based Wedgewood Pharmacy, the nation’s largest veterinary compounding pharmacy. -
Reed Smith announces Public Interest Law Initiative names Reed Smith to its 2023 Pro Bono Recognition Roster
Reed Smith once again has been named to the Pro Bono Recognition Roster of the Public Interest Law Initiative (PILI), which recognizes Reed Smith as one of 44 leading law firms and corporations providing pro bono services in Illinois. -
Reed Smith announces Reed Smith private equity / M&A partner Nick Gibson named an emerging leader by The M&A Advisor
Nick Gibson, a private equity/M&A partner at global law firm Reed Smith, was recognized as a recipient of the 14th Annual Emerging Leaders Awards by The M&A Advisor. -
Reed Smith announces Legal 500 USA ranks 46 Reed Smith practices and recognizes 16 lawyers
Global law firm Reed Smith ranked in 46 practice categories and 16 of its lawyers were recognized in 18 categories, in 2023 Legal 500 USA rankings issued. -
Sysco says third-party lawsuit funder Burford is blocking its attempts to settle lawsuits
Burford has obtained an international arbitrator’s award declaring it has the power under its contract with Sysco to veto settlement agreements that Burford believes are too little in light of its $140M investment in Sysco’s lawsuits -
Reed Smith advises TriMas Corp. on its agreement to acquire Weldmac Manufacturing Company
Global law firm Reed Smith announced that it has advised TriMas Corp. (TriMas) on its agreement to acquire the operating net assets of Weldmac Manufacturing Company, a manufacturer of engineered components and assemblies for the aerospace, defense, commercial power and space launch end markets. -
Reed Smith joins partnership with Children First Fund
Reed Smith joins partnership with Children First Fund. -
Patrick Yingling receives Chicago Bar Foundation’s 2022 Exceptional Young Lawyer Award
Patrick Yingling receives Chicago Bar Foundation’s 2022 Exceptional Young Lawyer Award. -
Reed Smith named by Public Interest Law Initiative to its 2022 Pro Bono Recognition Roster
Reed Smith named by Public Interest Law Initiative to its 2022 Pro Bono Recognition Roster. -
Reed Smith advises Golden Gate Capital in sale of PetroChoice
Reed Smith advises Golden Gate Capital in sale of PetroChoice. -
Peter M. Ellis of Reed Smith named a ‘Midwest Trailblazer’ by National Law Journal
Peter M. Ellis of Reed Smith named a ‘Midwest Trailblazer’ by National Law Journal. -
Judges nix consumer antitrust vs steelmakers; Production chain too complex to undergird sprawling class action
While noting the plaintiffs had presented statements which could indicate price-fixing activity, a federal appeals panel has refused to melt down a lower court’s decision to slice up a potentially massive class action lawsuit accusing U.S. steelmakers of conspiring to jack up prices for raw steel. -
Appeals court tosses $3M verdict vs GSK, says FDA, not drugmaker, controlled Paxil warning label
A federal appeals panel has tossed out a $3 million verdict vs GSK for the widow of a Chicago lawyer who committed suicide after taking the generic equivalent of GSK's drug, Paxil. The judges said the company can't be held responsible for language on the warning label when that language was controlled by the FDA. -
Grecian Delight says insurer refuses to pay more than $12M in claims from Elk Grove plant explosion
Elk Grove-based Greek food maker Grecian Delight has filed suit against its insurance company, claiming an insurer is crippling the company by refusing to pay out millions in claims after an explosion crippled the company’s food processing facility. -
Judge denies class action status for insurer’s suit against AbbVie, others over testosterone drugs
A Chicago federal judge has barred an Ohio health insurer from pursuing a class action against several pharmaceutical companies, which are already embroiled in massive litigation over their testosterone drugs, saying the thousands of potential claims would be too individualized to be served well by a class action and the insurer’s drug review practices were “unconventional.”